Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Total 13F shares
-
99,996,517
-
Share change
-
+15,953,105
-
Total reported value
-
$4,993,540,992
-
Put/Call ratio
-
414%
-
Price per share
-
$49.94
-
Number of holders
-
194
-
Value change
-
+$865,860,362
-
Number of buys
-
141
-
Number of sells
-
63
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2023
As of 30 Jun 2023 Vaxcyte, Inc. - COMMON STOCK (PCVX) had 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 99,996,517 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This table shows 194 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.